VITAMIN D
Hyperparathyroidism
Taipei Medical University HospitalmixturePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Hyperparathyroidism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Oxodotreotide National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | B |
FDOPA National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | B |
Same molecule, other indications
VITAMIN D is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →